Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Invited Paper

Free Access

Prevalence of Neurological Disorders in Bangalore, India: A Community-Based Study with a Comparison between Urban and Rural Areas

Gourie-Devi M.a · Gururaj G.b · Satishchandra P.a · Subbakrishna D.K.c

Author affiliations

Departments of aNeurology, bEpidemiology and cBiostatistics, National Institute of Mental Health & Neurosciences, Bangalore, India

Corresponding Author

Dr. M. Gourie-Devi

Flat 9, ‘Doctors Apartments’

Vasundhara Enclave, Delhi, 110 096 (India)

Tel. +91 11 2261 8573/7977, Fax +91 11 2575 1002

E-Mail gouriedevi@rediffmail.com or mgouriedevi@hotmail.com

Related Articles for ""

Neuroepidemiology 2004;23:261–268

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


A population-based neuroepidemiological survey of 102,557 individuals in urban and rural Bangalore in Southern India was conducted to determine the prevalence and pattern of neurological disorders. The study population included subjects from urban (51,502) and rural (51,055) areas, identified through a two-stage stratified random sampling method. Trained social workers administered the screening questionnaire, which had been tested and validated in an earlier pilot study and a neurologist examined the individuals who screened positive. Adults, children (<15 years) and elderly adults (>60 years) constituted 61, 34 and 5% of the study group, respectively. There was a distinct difference in education, occupation and income levels between urban and rural areas with all these parameters being lower in the rural population. In the surveyed population, 3,206 individuals with neurological disorders were detected resulting in crude and age-adjusted prevalence rates of 3,126 and 3,355 per 100,000 population, respectively. The prevalence rate among children, middle-aged (31–40 years) and elderly adults was 2,653, 3,932 and 5,012 per 100,000 population, respectively. The prevalence of neurological disorders among women (3,617) was higher compared with men (2,657). The prevalence rate in urban and rural populations was 2,190 and 4,070/1,00,000, respectively, implying that neurological disorders were twice as frequent in rural areas as in urban areas. The prevalence rates per 100,000 population of the most frequent disorders in the descending order of frequency were: headache (1,119), epilepsy (883), febrile convulsions (330), cerebrovascular disorder (150), and mental retardation (142). This large-scale population-based survey provides data that will be crucial for developing hospital and community-based neurological services in India and other developing countries.

© 2004 S. Karger AG, Basel


  1. Chandra V, Pandav CS: The importance of non-communicable diseases in developing countries (editorial). Ind J Com Med 1987;12:178–180.
  2. Gourie-Devi M: Can India afford neuroepidemiology (editorial), Neurol India 1987;35:125–127.
  3. Gourie-Devi M, Rao VN, Prakashi R: Neuroepidemiological study in semi-urban and rural areas in South India: Pattern of neurological disorders including motor neurone disease; in Gourie-Devi M (ed): Motor Neurone Disease: Global Clinical Patterns and International Research. New Delhi, Oxford & IBH, 1987, pp 11–21.
  4. Razdan S, Kaul Rh, Motta A, Kaul S, Bhatt RK: Prevalence and pattern of major neurological disorders in rural Kashmir (India) in 1986. Neuroepidemiology 1994;13:113–119.
  5. Bharucha NE, Bharucha EP, Dastur HD, Schoenberg BS: Pilot survey of the prevalence of neurologic disorders in the Parsi Community of Bombay, Am J Prev Med 1987;3:293–299.
  6. WHO study group: The application of advances in Neurosciences for the control of neurological disorders. World Health Organ Tech Rep Ser. Geneva, WHO, 1978, p 629.
  7. Kurtzke JF: Neuroepidemiology. Ann Neurol 1984;16:265–277.
  8. Schoenberg BS: Clinical neuroepidemiology in developing countries. Neuroepidemiology 1982;1:137–142.
    External Resources
  9. Gourie-Devi M, Gururaj G, Satishchandra P, Subbakrishna DK: Neuroepidemiological pilot survey of an urban population in a developing country. A study in Bangalore, South India. Neuroepidemiology 1996;15:313–320.
  10. Gourie-Devi M, Gururaj G, Satishchandra P: A Manual for Descriptive Studies: Neuroepidemiology in Developing Countries, ed 2. Bangalore, Prism, 1997.
  11. Director of Census operations. Census of India 1991. Karnataka Series II. Government of India, 1991.
  12. Gourie-Devi M, Anderson DW, Rao VN: Neuroepidemiologic survey in a developing country: Some questions and answers; in Anderson DW, Schoenberg DG (eds): Neuroepidemiology: A Tribute to Bruce Schoenberg. Boston, CRC, 1991, pp 13–23.
  13. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TG: Epi Info, Version 6: A word processing, database, and statistics program for epidemiology on microcomputers. Atlanta, Centers for Disease Control and Prevention, 1994.
  14. Kapoor SK, Chandra V, Banerjee AK, Nath LM, Schoenberg BS: Pilot study of the prevalence of major neurologic disorders in a rural population of India. Neuroepidemiology 1990;9:287–295.
  15. Haimnot RT, Abebe M, Mariam AG, Forsgen L, Heijbel J, Holmgren G, Ekstedt J: Community based study of neurological disorders in rural Central Ethiopia. Neuroepidemiology 1990;9:263–277.
  16. Cruz Gutierrez-del-Olmo M, Schoenberg BS, Portera-Sanchez A: Prevalence of neurological diseases in Madrid, Spain. Neuroepidemiology 1989;8:43–47.
  17. Meneghini F, Rocca WA, Grigoleno F, et al: Door-to-door prevalence survey of neurological disease in Sicilian population: Background and methods. Neuroepidemiology 1991;10:70–85.
  18. Das SK and Sanyal K: Neuroepidemiology of major neurological disorders in rural Bengal. Neurol India 1996;44:47–58.
    External Resources
  19. Romdhane NA, Hamida BM, Mrabet A, et al: Prevalence study of neurologic disorders in Kelibia (Tunisia). Neuroepidemiology 1993;12:285–299.
  20. Osuntokun BO, Adeuja AOG, Schoenberg BS, et al: Neurological disorders in Nigerian Africans: A community based study. Acta Neurol Scand 1987;75:13–21.
  21. Haerer AF, Anderson OW, Schoenberg BS: Prevalence of essential tremor. Results from the Copiah County study. Arch Neurol 1982;39:750–751.
  22. Li SC, Schoenberg BS, Wang CC, et al: Epidemiology of epilepsy in urban areas of the People’s Republic of China. Epilepsia 1985;26:391–394.
  23. Gourie-Devi M, Gururaj G, Satishchandra P: Neuroepidemiology in India. A perspective; in Clifford R (ed): Recent Advances in Tropical Neurology. Elsevier, 1995, pp 17–30.
  24. Gourie-Devi M, Gururaj G, Satishchandra P: Neuroepidemiology in India: Development during three decades. NIMHANS J 1999;17:279–287.
  25. Gourie-Devi M, Gururaj G, Satishchandra P: Epidemiology: Present insights and future prospects. NIMHANS J 1999;17:423–437.

Article / Publication Details

First-Page Preview
Abstract of Invited Paper

Published online: September 16, 2004
Issue release date: November – December

Number of Print Pages: 8
Number of Figures: 1
Number of Tables: 5

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.